Literature DB >> 9150036

Expression of extracellular matrix proteins in human periodontal ligament cells during mineralization in vitro.

R M Nohutcu1, L K McCauley, A J Koh, M J Somerman.   

Abstract

Periodontal regeneration is a complex process that requires coordinated responses from several cell types within the periodontium. It is generally accepted that the periodontal ligament (PDL) has a heterogeneous cell population, where some of the cells may be capable of differentiating into either cementoblasts or osteoblasts. Thus, it has been hypothesized that PDL cells play a role in promoting periodontal regeneration. However, definitive evidence to support this concept is lacking. Previously, we reported that PDL cells induce biomineralization as determined by Von Kossa histochemistry and transmission electron microscopy. To further determine the osteoblast-like properties of PDL cells, human PDL cells were exposed to dexamethasone (DEX) in order to promote an osteoblast phenotype, and then cell activity monitored during mineral nodule formation in vitro. For mineralization studies, cells were cultured in DMEM containing 10% FBS and a) vehicle only; b) ascorbic acid (50 micrograms/ml) and beta-glycerophosphate (10 mM); or c) ascorbic acid, beta-glycerophosphate and DEX (100 nM) for 30 days. In addition, the effects of DEX on PDL cells in non-mineralizing media were determined. Cells were stained weekly to evaluate mineral-like nodules, using the Von Kossa method. Northern blot analyses for mRNA steady state levels for several bone-associated proteins, i.e., osteopontin (OPN), bone sialoprotein (BSP), alkaline phosphatase (ALP), osteocalcin (OCN), alpha 2(1)(type 1) collagen and osteonectin (ON), were performed. DNA levels were also determined during the 30-day mineralization period. Under phase contrast microscopy, PDL cells in non-mineralizing media treated with DEX exhibited a more spindle-shaped morphology when compared with similar cells not exposed to DEX. Mineralizing conditions were required to induce mineral nodule formation. However, in this situation, mineral induction was independent of DEX; and furthermore, DEX-treated cells did not exhibit a different morphological pattern when compared with non-DEX treated cells. Mineral-like nodules were first seen at day 15, in concert with an increase followed by a decrease in expression of type I collagen and ON mRNA in both DEX-treated and non-treated cultures. Using Northern blot analysis for detection of specific proteins, we found that PDL cells did not express OPN, BSP, OCN, or ALP under any of the conditions used in this study. DEX did not alter DNA content in the cultures during the mineralization period. These results confirm that human periodontal ligament cells can be induced to mineralize in vitro and indicate that dexamethasone does not significantly alter the extent and pattern of mineralization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150036     DOI: 10.1902/jop.1997.68.4.320

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  19 in total

1.  Differentiation of neural-crest-derived intermediate pluripotent progenitors into committed periodontal populations involves unique molecular signature changes, cohort shifts, and epigenetic modifications.

Authors:  Smit Jayant Dangaria; Yoshihiro Ito; Xianghong Luan; Thomas G H Diekwisch
Journal:  Stem Cells Dev       Date:  2010-09-06       Impact factor: 3.272

2.  In vivo differentiation of human periodontal ligament cells leads to formation of dental hard tissue.

Authors:  M Wolf; S Lossdörfer; N Abuduwali; R Meyer; S Kebir; W Götz; A Jäger
Journal:  J Orofac Orthop       Date:  2013-11-01       Impact factor: 1.938

3.  Two distinct processes of bone-like tissue formation by dental pulp cells after tooth transplantation.

Authors:  Akihiro Hosoya; Akira Yukita; Kunihiko Yoshiba; Nagako Yoshiba; Masafumi Takahashi; Hiroaki Nakamura
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

4.  Correction of hypophosphatasia-associated mineralization deficiencies in vitro by phosphate/pyrophosphate modulation in periodontal ligament cells.

Authors:  Thaisângela L Rodrigues; Brian L Foster; Karina G Silverio; Luciane Martins; Marcio Z Casati; Enilson A Sallum; Martha J Somerman; Francisco H Nociti
Journal:  J Periodontol       Date:  2011-10-20       Impact factor: 6.993

5.  A cleft lip and palate gene, Irf6, is involved in osteoblast differentiation of craniofacial bone.

Authors:  Jake Thompson; Fabian Mendoza; Ethan Tan; Jessica Wildgrube Bertol; Arju S Gaggar; Goo Jun; Claudia Biguetti; Walid D Fakhouri
Journal:  Dev Dyn       Date:  2019-02-07       Impact factor: 3.780

6.  Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro.

Authors:  Dominik Kraus; Andreas Jäger; Nuersailike Abuduwali; James Deschner; Stefan Lossdörfer
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

7.  PTH(1-34)-induced changes in RANKL and OPG expression by human PDL cells modify osteoclast biology in a co-culture model with RAW 264.7 cells.

Authors:  Stefan Lossdörfer; Werner Götz; Andreas Jäger
Journal:  Clin Oral Investig       Date:  2010-08-10       Impact factor: 3.573

8.  Defining a visual marker of osteoprogenitor cells within the periodontium.

Authors:  S M San Miguel; M R Fatahi; H Li; J C Igwe; H L Aguila; I Kalajzic
Journal:  J Periodontal Res       Date:  2009-04-30       Impact factor: 4.419

9.  N-terminal region of human ameloblastin synthetic peptide promotes bone formation.

Authors:  Masae Kitagawa; Toshinori Ando; Ajiravudh Subarnbhesaj; Takashi Uchida; Mutsumi Miyauchi; Takashi Takata
Journal:  Odontology       Date:  2016-06-04       Impact factor: 2.634

10.  MMP-1 (collagenase-1) and MMP-13 (collagenase-3) differentially regulate markers of osteoblastic differentiation in osteogenic cells.

Authors:  Takayuki Hayami; Yvonne L Kapila; Sunil Kapila
Journal:  Matrix Biol       Date:  2008-08-05       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.